ANALYST RECOMMENDATIONS : Exxon Mobil, Sherwin-Williams, UnitedHealth, US Bancorp, Wells Fargo...
Every day, find a selection of analysts' recommendations covering North America and the UK. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information is used to shed light on the movements of certain stocks or the market sentiment on a company.
- Cboe: Morgan Stanley upgrades to overweight from underweight. PT up 18% to $140.
- ChargePoint Holdings: Fox Advisors upgrades to overweight from equalweight, sets $15 price target.
- Exxon Mobil: Piper Sandler upgrades to overweight from neutral, adjusts price target to $109 from $102
- Fevertree Drinks: HSBC upgrades from Buy to Hold with a GBp 800 price target.
- Haleon: Barclays starts coverage with an equal weight rating and a 3.48 pounds sterling price target.
- PPG industries: Wells Fargo Securities adjusts price target to $126 from $140, maintains equal weight rating.
- The Sherwin-Williams Company: Wells Fargo Securities adjusts price target to $270 from $285, maintains equalweight rating.
- UnitedHealth: Goldman Sachs remains Buy with a price target raised from USD 605 to USD 625.
- US Bancorp: Morgan Stanley remains neutral but with a price target raised from 54 to 57 USD.
- Vodafone: Oddo BHF resumes its monitoring at neutral with a price target of GBp 140.
- Vulcan Materials: Morgan Stanley adjusts price target to $180 from $203, maintains equalweight rating
- Wells Fargo: Morgan Stanley adjusts price target to $62 from $59, maintains overweight rating.
- Whitbread: Peel Hunt downgrades to add from buy. PT up 7.3% to 2,850 pence.
- W.W. Grainger: Morgan Stanley adjusts price target to $421 from $449, maintains underweight rating.
- Zimmer BioMet Holdings: Morgan Stanley adjusts price target to $115 from $132, maintains equal weight rating.
By 
